Acute renal failure (ARF) is frequently associated with
polyuria and urine concentration defects and it is a severe complication of
sepsis because it increases the mortality rate. Inhibition of
NF-kappaB activation has been suggested to provide a useful strategy for the treatment of
septic shock. However, the impact on
sepsis-induced ARF is still unclear. Therefore, we examined the effect of
pyrrolidine dithiocarbamate (
PDTC) and of
small interfering RNA (
siRNA) silencing
NF-kappaB p50/p105 on
sepsis-induced downregulation of
vasopressin V(2) receptors and
aquaporin (AQP)-2 channels using a cecal
ligation and
puncture (CLP) mouse model. CLP caused a time-dependent downregulation of renal
vasopressin V(2) receptor and of AQP2 expression without alterations in plasma
vasopressin levels. Renal activation of
NF-kappaB in response to CLP was attenuated by
PDTC pretreatment, which also attenuated the downregulation of V(2) receptor and AQP2 expression. Furthermore, a strong nuclear staining for the
NF-kappaB p50 subunit throughout the whole kidney in response to CLP was observed.
siRNA against
NF-kappaB p50 attenuated the CLP-induced nuclear translocation of the p50 subunit and the CLP-induced downregulation of V(2) receptor and AQP2 expression. Additionally,
PDTC and
siRNA pretreatment inhibited the CLP-induced increase in renal
TNF-alpha and IL-1beta concentration and NOS-2
mRNA abundance. Moreover,
PDTC and
siRNA pretreatment ameliorated CLP-
induced hypotension and ARF. Our findings suggest that
NF-kappaB activation is of importance for the downregulation of AQP2 channel and
vasopressin V(2) receptor expression during
sepsis. In addition, our data indicate that
NF-kappaB inhibition ameliorates
sepsis-induced ARF.